Published in J Comp Neurol on June 21, 1999
Candidate gene studies of ADHD: a meta-analytic review. Hum Genet (2009) 3.56
What can we learn from rodents about prolactin in humans? Endocr Rev (2007) 2.38
Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum Mol Genet (2005) 2.28
Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis. Mol Psychiatry (2013) 1.86
Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci Biobehav Rev (2009) 1.57
Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res (2004) 1.55
Ventral-striatal responsiveness during reward anticipation in ADHD and its relation to trait impulsivity in the healthy population: a meta-analytic review of the fMRI literature. Neurosci Biobehav Rev (2013) 1.51
Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci (2007) 1.46
Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. Neuropsychopharmacology (2011) 1.18
The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity. J Neurochem (2011) 1.17
Preweaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels. Synapse (2010) 1.14
Dopamine innervation in the thalamus: monkey versus rat. Cereb Cortex (2008) 1.14
Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers. Neuropsychopharmacology (2011) 1.10
Cortical dopaminergic innervation among humans, chimpanzees, and macaque monkeys: a comparative study. Neuroscience (2008) 1.09
Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate. PLoS One (2010) 1.07
Striatal sensitivity during reward processing in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2012) 1.04
Human cognitive flexibility depends on dopamine D2 receptor signaling. Psychopharmacology (Berl) (2011) 1.03
Long-term health of dopaminergic neuron transplants in Parkinson's disease patients. Cell Rep (2014) 1.02
Acute effects of modafinil on brain resting state networks in young healthy subjects. PLoS One (2013) 1.02
Selective enrichment of DJ-1 protein in primate striatal neuronal processes: implications for Parkinson's disease. J Comp Neurol (2007) 0.99
Dopamine transporter gene variation modulates activation of striatum in youth with ADHD. Neuroimage (2009) 0.98
Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS). Mol Neurobiol (2014) 0.96
Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach. Neuroimage (2012) 0.96
Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversity. PLoS One (2010) 0.96
Dopamine: a parallel pathway for the modulation of spinal locomotor networks. Front Neural Circuits (2014) 0.93
Species-specific distributions of tyrosine hydroxylase-immunoreactive neurons in the prefrontal cortex of anthropoid primates. Neuroscience (2008) 0.93
Future of cell and gene therapies for Parkinson's disease. Ann Neurol (2008) 0.92
Extrastriatal dopaminergic circuits of the Basal Ganglia. Front Neuroanat (2010) 0.92
Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans. Hum Brain Mapp (2010) 0.89
The external globus pallidus: progress and perspectives. Eur J Neurosci (2016) 0.89
Immunohistochemical investigation of dopaminergic terminal markers and caspase-3 activation in the striatum of human methamphetamine users. Int J Legal Med (2006) 0.88
Fas-associated factor 1 and Parkinson's disease. Neurobiol Dis (2008) 0.88
Subcellular distribution of M2 muscarinic receptors in relation to dopaminergic neurons of the rat ventral tegmental area. J Comp Neurol (2006) 0.85
Characterization of A11 neurons projecting to the spinal cord of mice. PLoS One (2014) 0.85
Where and what is the paralaminar nucleus? A review on a unique and frequently overlooked area of the primate amygdala. Neurosci Biobehav Rev (2011) 0.84
Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders. Pharmacol Rev (2015) 0.84
Frontal-thalamic circuits associated with language. Brain Lang (2012) 0.84
Brain Region-Specific Trafficking of the Dopamine Transporter. J Neurosci (2015) 0.84
Dopamine Transporter Activity Is Modulated by α-Synuclein. J Biol Chem (2015) 0.84
Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter. Neuropsychopharmacology (2013) 0.83
Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathway. PLoS One (2014) 0.82
Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine. PET Clin (2009) 0.82
Dopaminergic differentiation of schizophrenia hiPSCs. Mol Psychiatry (2015) 0.81
Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study. Eur J Nucl Med Mol Imaging (2006) 0.81
Glutathione deficiency in Gclm null mice results in complex I inhibition and dopamine depletion following paraquat administration. Toxicol Sci (2013) 0.81
Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia. J Psychiatry Neurosci (2014) 0.81
Redistribution of DAT/α-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's disease. PLoS One (2011) 0.80
Influence of the COMT val(108/158)met polymorphism on continuous performance task indices. Neuropsychologia (2014) 0.80
Reduced dopamine transporter expression in the amygdala of subjects diagnosed with schizophrenia. Schizophr Bull (2014) 0.79
Catecholamines and cognition after traumatic brain injury. Brain (2016) 0.78
Ex vivo identification of protein-protein interactions involving the dopamine transporter. J Neurosci Methods (2011) 0.78
Preliminary investigation of the influence of dopamine regulating genes on social working memory. Soc Neurosci (2014) 0.78
A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism. Behav Brain Funct (2015) 0.78
Topological and chronological features of the impairment of glucose metabolism induced by 1-methyl-4-phenylpyridinium ion (MPP+) in rat brain slices. J Neural Transm (Vienna) (2007) 0.78
Decreasing ADHD phenotypic heterogeneity: searching for neurobiological underpinnings of the restrictive inattentive phenotype. Eur Child Adolesc Psychiatry (2015) 0.78
Dopamine is produced in the rat spinal cord and regulates micturition reflex after spinal cord injury. Exp Neurol (2015) 0.77
Somatodendritic targeting of M5 muscarinic receptor in the rat ventral tegmental area: implications for mesolimbic dopamine transmission. J Comp Neurol (2013) 0.77
Immunization with DAT fragments is associated with long-term striatal impairment, hyperactivity and reduced cognitive flexibility in mice. Behav Brain Funct (2012) 0.77
Putaminal Mosaic Visualized by Tyrosine Hydroxylase Immunohistochemistry in the Human Neostriatum. Front Neuroanat (2016) 0.76
Methylphenidate effects on brain activity as a function of SLC6A3 genotype and striatal dopamine transporter availability. Neuropsychopharmacology (2014) 0.76
Dopamine transporter gene susceptibility to methylation is associated with impulsivity in nonhuman primates. J Neurophysiol (2014) 0.76
Decision making: effects of methylphenidate on temporal discounting in nonhuman primates. J Neurophysiol (2015) 0.75
Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users. Drug Alcohol Depend (2016) 0.75
Enlarged striatal volume in adults with ADHD carrying the 9-6 haplotype of the dopamine transporter gene DAT1. J Neural Transm (Vienna) (2016) 0.75
Manganese inhalation as a Parkinson disease model. Parkinsons Dis (2010) 0.75
An immunohistochemical analysis of SERT in the blood-brain barrier of the male rat brain. Histochem Cell Biol (2015) 0.75
COMT and DAT1 genes are associated with hyperactivity and inattention traits in the 1993 Pelotas Birth Cohort: evidence of sex-specific combined effect. J Psychiatry Neurosci (2016) 0.75
A descending dopamine pathway conserved from basal vertebrates to mammals. Proc Natl Acad Sci U S A (2016) 0.75
Effects of dopaminergic genes, prenatal adversities, and their interaction on attention-deficit/hyperactivity disorder and neural correlates of response inhibition. J Psychiatry Neurosci (2017) 0.75
Reward modulation of cognitive function in adult attention-deficit/hyperactivity disorder: a pilot study on the role of striatal dopamine. Behav Pharmacol (2015) 0.75
Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease. Neuroimage Clin (2017) 0.75
Nigral Tau pathology and striatal amyloid-β deposition does not correlate with striatal dopamine deficit in Alzheimer's disease. J Neural Transm (Vienna) (2012) 0.75
Targeting of dopamine transporter to filopodia requires an outward-facing conformation of the transporter. Sci Rep (2017) 0.75
Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron (1996) 5.30
Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron (1996) 5.14
Localization of neuronal and glial glutamate transporters. Neuron (1994) 5.14
Insula of the old world monkey. III: Efferent cortical output and comments on function. J Comp Neurol (1982) 4.23
A new complement function: solubilization of antigen-antibody aggregates. Proc Natl Acad Sci U S A (1975) 3.97
Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol (1995) 3.66
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med (1995) 3.64
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology (2007) 3.26
Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience (1983) 3.26
Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med (1996) 3.23
Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol (1983) 3.19
Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci (1998) 3.16
Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol (1998) 2.92
Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci (1998) 2.81
Perinatal transmission of the agent of human granulocytic ehrlichiosis. N Engl J Med (1998) 2.61
Insula of the old world monkey. I. Architectonics in the insulo-orbito-temporal component of the paralimbic brain. J Comp Neurol (1982) 2.57
Insula of the old world monkey. II: Afferent cortical input and comments on the claustrum. J Comp Neurol (1982) 2.54
Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol (2001) 2.51
Human lymphocytes bear membrane receptors for C3b and C3d. J Clin Invest (1973) 2.46
Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci U S A (2001) 2.46
Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach. J Acquir Immune Defic Syndr (1993) 2.36
Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol (1997) 2.35
Complement-dependent release of immune complexes from the lymphocyte membrane. J Exp Med (1973) 2.27
The dysarthria-clumsy hand syndrome: a distinct clinical entity related to pontine infarction. Ann Neurol (1990) 2.25
Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci U S A (1997) 2.10
Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience (2003) 2.02
Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies. J Neurosci (1994) 1.98
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci (2000) 1.93
Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci (1995) 1.91
Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci U S A (1990) 1.90
The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci (1995) 1.89
Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron (1997) 1.89
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat Neurosci (2000) 1.88
Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron (2001) 1.87
Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nat Med (1997) 1.86
Complement as a regulator of interactions between immune complexes and cell membranes. J Immunol (1974) 1.83
Some observations on the course and composition of the cingulum bundle in the rhesus monkey. J Comp Neurol (1984) 1.79
Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci (1996) 1.78
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurol Scand (2009) 1.75
Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann Neurol (1999) 1.75
Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. J Neurosci (2000) 1.69
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res (1992) 1.69
Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience (1995) 1.68
Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci (2001) 1.66
AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience (1993) 1.66
Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors. J Immunol (1985) 1.64
Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc Natl Acad Sci U S A (1998) 1.61
D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc Natl Acad Sci U S A (1994) 1.60
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res (1990) 1.60
Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci (1999) 1.59
Biochemical characterization and localization of a non-N-methyl-D-aspartate glutamate receptor in rat brain. J Neurochem (1992) 1.58
D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci U S A (1991) 1.55
Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry (2000) 1.54
Frequency and type of electrocardiographic abnormalities in cocaine abusers (electrocardiogram in cocaine abuse). Am J Cardiol (1994) 1.53
Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase. Neuroscience (1984) 1.52
Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci U S A (1995) 1.50
Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Ann Neurol (1991) 1.49
Neural inputs into the temporopolar cortex of the rhesus monkey. J Comp Neurol (1987) 1.49
The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects. Exp Neurol (1989) 1.45
Isolation and characterization of virus-specific double-stranded DNA from tissues infected by bean golden mosaic virus. Proc Natl Acad Sci U S A (1981) 1.45
Distribution of cholinergic neurons in rat brain: demonstrated by the immunocytochemical localization of choline acetyltransferase. J Comp Neurol (1983) 1.44
Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity. J Forensic Sci (1997) 1.43
Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience (1998) 1.43
The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine. Psychopharmacology (Berl) (2004) 1.42
The origins of cholinergic and other subcortical afferents to the thalamus in the rat. J Comp Neurol (1987) 1.41
Light and electron microscopic localization of presenilin-1 in primate brain. J Neurosci (1997) 1.40
Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease. Ann Neurol (1999) 1.40
[Diagnosis of Alzheimer's disease. Evaluation of senile plaques of the diffuse type]. Med Clin (Barc) (1992) 1.40
Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J Comp Neurol (1998) 1.39
Dopamine transporters and neuronal injury. Trends Pharmacol Sci (1999) 1.39
Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Neuroscience (1984) 1.38
Tau pathology in a family with dementia and a P301L mutation in tau. J Neuropathol Exp Neurol (1999) 1.38
Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol (1997) 1.38
Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci U S A (2009) 1.37
Circuit-specific alterations of N-methyl-D-aspartate receptor subunit 1 in the dentate gyrus of aged monkeys. Proc Natl Acad Sci U S A (1996) 1.37
Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons. Synapse (1997) 1.37
Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J Neurosci (1996) 1.36
Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proc Natl Acad Sci U S A (2007) 1.34
Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission. Proc Natl Acad Sci U S A (1993) 1.34
Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 1.33
Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse (2000) 1.31
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med (2013) 1.31
Dopaminergic neurons intrinsic to the primate striatum. J Neurosci (1997) 1.31
Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology (1996) 1.30
Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res (1992) 1.30
Catechols in post-mortem brain of patients with Parkinson disease. Eur J Neurol (2010) 1.30
Deficiency of C7 with systemic lupus erythematosus: solubilization of immune complexes in complement-deficient sera. Arthritis Rheum (1981) 1.30
Alterations in cortical thickness and white matter integrity in mild cognitive impairment measured by whole-brain cortical thickness mapping and diffusion tensor imaging. AJNR Am J Neuroradiol (2009) 1.29
Complement-dependent alterations in the handling of immune complexes by NZB/W mice. J Immunol (1975) 1.28
Butyrylcholinesterase in the life cycle of amyloid plaques. Ann Neurol (1997) 1.27
Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol (1996) 1.27
Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann Neurol (1997) 1.27
Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci (1995) 1.26
Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science (1985) 1.26